Phase I clinical trial of an oral histone deacetylase inhibitor: Suberoylanilide hydroxamic acid (SAHA) Meeting Abstract
| Authors: | Kelly, W. K.; O'connor, O.; Richon, V. M.; Curley, T.; Richardson, S.; Thapi, D.; Chiao, J. H.; Rifkind, R. A.; Marks, P. A.; Scher, H. I. |
| Abstract Title: | Phase I clinical trial of an oral histone deacetylase inhibitor: Suberoylanilide hydroxamic acid (SAHA) |
| Meeting Title: | 2003 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics |
| Journal Title: | Clinical Cancer Research |
| Volume: | 9 |
| Issue: | 16 Pt. 2 |
| Meeting Dates: | 2003 Nov 17-21 |
| Meeting Location: | Boston, MA |
| ISSN: | 1078-0432 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2003-12-01 |
| Start Page: | 6245s |
| End Page: | 6246s |
| Language: | English |
| ACCESSION: | WOS:000187467300719 |
| PROVIDER: | wos |
| PUBMED: | 14712828 |
| Notes: | Meeting Abstract: #C174 -- Poster Session C -- Source: Wos |
Citation Impact
